Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
Neil Mabbott, Personal Chair of Immunopathology, The University of Edinburgh

Bivalent COVID vaccines have now been in use for a few months – here's how they're stacking up against omicron

Bivalent vaccines target omicron alongside the original strain of COVID. Lithiumphoto/Shutterstock

Vaccines have played a major role in mitigating the harms of the COVID pandemic since their rollout began just over two years ago. They’re estimated to have saved tens of millions of lives around the globe.

The initial crop of COVID vaccines was designed to train our immune systems to recognise the spike protein on the surface of the original strain of SARS-CoV-2 (the virus that causes COVID-19). But as we well know, since SARS-CoV-2 was first identified it has continued to mutate and evolve into a range of distinct variants.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.